Laurids P.
- Country
- Denmark
- Department
- Oncology
Research Overview
- Evaluation of [Main Substance] in Combination with Other Agents for Patients with BRAF V600E Mutated Colorectal Cancer
- Sotorasib and Combination Therapy Versus Standard Chemotherapy in Treatment-Naïve Patients with KRAS p.G12C-Mutated Metastatic Colorectal Cancer
- Efficacy and Safety of PF-08634404 and Combination Therapy Versus Bevacizumab and Combination Therapy in Treatment-Naïve Participants With Metastatic Colorectal Cancer
Data & Insights
Has run more than one trial at 84 of 234 partner sites.
Specializations
Colorectal Cancer Research
The investigator specializes in treating advanced forms of colorectal cancer, with particular emphasis on specific genetic mutations and molecular characteristics. Their research encompasses BRAF V600E mutations and microsatellite instability-high (MSI-H) cases.
- BRAF V600E-mutant Colorectal Cancer
- MSI-H/dMMR Metastatic Disease
- Locally Advanced Rectal Cancer
Their expertise extends to neoadjuvant treatment approaches for rectal cancer management.
Gastric Cancer Studies
The investigator focuses on advanced gastrointestinal malignancies, including gastric adenocarcinoma and related conditions affecting the upper digestive tract.
- Advanced Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
- Esophageal Adenocarcinoma
Their research addresses metastatic disease and innovative therapeutic approaches for these conditions.
Therapeutic Approaches
The investigator's work involves evaluating various treatment modalities and combinations for gastrointestinal cancers, including immunotherapy and targeted therapies.
- Combined Targeted Therapy
- Immunotherapy Applications
- Neoadjuvant Chemotherapy
Their research explores both standard and experimental therapeutic strategies for advanced-stage cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.